TG THERAPEUTICS INC. - COMMON STOCK
13.46
19-April-24 14:24:30
15 minutes delayed
Stocks
-0.54
-3.82%
Today's range
13.26 - 14.02
ISIN
N/A
Source
NASDAQ
-
18 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
18 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
15 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
08 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
01 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 06:00:01 By Nasdaq GlobeNewswire
-
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
27 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)
26 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
23 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
10 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
05 Jan 2024 06:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
27 Nov 2023 06:30:00 By Nasdaq GlobeNewswire
-
03 Nov 2023 06:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
01 Nov 2023 06:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics to Host Conference Call on Third Quarter 2023 Financial Results and Business Update
30 Oct 2023 06:30:00 By Nasdaq GlobeNewswire
-
12 Oct 2023 10:00:00 By Nasdaq GlobeNewswire
-
11 Oct 2023 09:30:26 By Nasdaq GlobeNewswire
-
02 Oct 2023 06:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >